Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Rev Med Suisse ; 9(372): 332-6, 2013 Feb 06.
Artículo en Francés | MEDLINE | ID: mdl-23469402

RESUMEN

Atrial fibrillation (AF) is the most common cardiac arrhythmia. The risk of thromboembolic events is important, and at that time, there is no definite treatment for AF. Oral anticoagulation also represents a hemorrhagic risk factor. Ninety percent of atrial thrombi are located within the left atrial appendage. The percutaneous closure of this left atrial appendage with a device has been shown to decrease thromboembolic events even after interruption of oral anticoagulation as compared to warfarin in a recent randomized study. Recent data support this innovative technique as a reasonable alternative to long term anticoagulation in patients at high risk of bleeding.


Asunto(s)
Apéndice Atrial/cirugía , Fibrilación Atrial/complicaciones , Tromboembolia/etiología , Tromboembolia/prevención & control , Procedimientos Quirúrgicos Cardíacos/métodos , Humanos , Riesgo
2.
Rev Med Suisse ; 2(52): 415-7, 2006 Feb 08.
Artículo en Francés | MEDLINE | ID: mdl-16521718

RESUMEN

Lyme disease is the most common tick-borne disease in Europe and in the United States. In comparison to dermatological, neurological and rheumatological manifestations, heart disease is quite rare. Atrioventricular heart block is nevertheless the most frequent cardiological manifestation. We hereby report the case of a patient with high degree heart block due to Lyme disease. We focus on the electrocardiographical evolution during antibiotic therapy, as well as on microbiological and diagnostic aspects. Lyme disease is a rare cause of conduction disturbances but it is treatable and potentially reversible.


Asunto(s)
Nodo Atrioventricular/fisiopatología , Bloqueo Cardíaco/microbiología , Enfermedad de Lyme/diagnóstico , Antibacterianos/uso terapéutico , Bloqueo Cardíaco/tratamiento farmacológico , Humanos , Enfermedad de Lyme/tratamiento farmacológico , Enfermedad de Lyme/fisiopatología , Masculino , Persona de Mediana Edad
3.
Rev Med Suisse ; 2(49): 232-4, 236-9, 2006 Jan 18.
Artículo en Francés | MEDLINE | ID: mdl-16493966

RESUMEN

Heart failure and atrial fibrillation are the main problems in general cardiology. Our therapeutic reflections summarize new ideas in the treatment of theses pathologies but we will not forget importance of PCI. All these therapies have proven now the clinical benefit but also reduction in more morbidity and mortality. Cardiac resynchronisation therapy has shown promising results. The art of medicine to develop will be to better identify the patients benefiting from this therapy. Interventional cardiology is focusing on the acute coronary syndrome. Not only rapid intervention but also the stent technology allow significant modification of endothelial tissue reaction and therefore improve the general benefit for the patient.


Asunto(s)
Fibrilación Atrial/terapia , Insuficiencia Cardíaca/terapia , Fibrilación Atrial/patología , Cardiología/tendencias , Insuficiencia Cardíaca/patología , Humanos , Antagonistas de Receptores de Mineralocorticoides , Marcapaso Artificial
5.
Rev Med Suisse ; 1(2): 105-6, 108-11, 2005 Jan 12.
Artículo en Francés | MEDLINE | ID: mdl-15773209

RESUMEN

The therapeutic acquisition to be retained for 2004 are: 1. The elderly patients with heart failure also should receive beta blocker treatment. The correction of anaemia, aggravating factor in heart failure, improves symptoms and survival of the patient. 2. It remains to prove that the treatment of sleep apnea, which seems to be an additional factor for mortality in cardiovascular diseases, is able to reduce the risk. 3. The interventions in the endocanabinoïd system which regulates weight and metabolic processes might be a promising new therapeutic acquisition. 4. Prevention of coronary disease with lipid lowering drugs is still a major topic, and the trend goes the lower the better. The problems observed with Rofecoxybe and other drug interactions reminds us to be conscious when prescribing multiple drugs. 5. The implantable defibrillator seems to be a life insurance in the event of ventricular fibrillation. However, it is not so easy to identify the patient who might really benefit.


Asunto(s)
Cardiopatías , Enfermedades Cardiovasculares/etiología , Enfermedades Cardiovasculares/prevención & control , Desfibriladores Implantables , Cardiopatías/complicaciones , Cardiopatías/etiología , Cardiopatías/terapia , Insuficiencia Cardíaca/complicaciones , Insuficiencia Cardíaca/terapia , Humanos , Factores de Riesgo , Apnea Obstructiva del Sueño/complicaciones
6.
Arch Mal Coeur Vaiss ; 97(10): 987-93, 2004 Oct.
Artículo en Francés | MEDLINE | ID: mdl-16008176

RESUMEN

About a quarter of the adult population is known to have a patent foramen ovale, rarely accompanied by the presence of an interatrial septal aneurysm. A patent foramen ovale is found in more than 40% of patients younger than 60 years who had a cryptogenic ischemic stroke. Clinical and echocardiographic parameters allow the identification of patients at high risk of recurrence after a first cryptogenic stroke even if treated with Aspirin. A multidisciplinary approach allow the selected patients to benefit of a correction of their cardiac anomaly with promising long term results.


Asunto(s)
Defectos del Tabique Interatrial/complicaciones , Accidente Cerebrovascular/etiología , Adulto , Edad de Inicio , Aspirina/uso terapéutico , Humanos , Persona de Mediana Edad , Inhibidores de Agregación Plaquetaria/uso terapéutico , Recurrencia , Factores de Riesgo
7.
Arch Mal Coeur Vaiss ; 96(6): 624-30, 2003 Jun.
Artículo en Francés | MEDLINE | ID: mdl-12868343

RESUMEN

OVERVIEW: Arterial hypotension during stress echocardiography with Dobutamine (ESD) is an occasional complication with no prognostic value, but it sometimes necessitates termination of the investigation. The present study had the aim of elucidating the mechanism responsible for hypotension during ESD and proposing one or several markers for patients at risk for this complication. METHOD: One hundred and twenty consecutive patients referred for stress echocardiography (Dobutamine or cycloergometrine) were analysed. Arterial hypotension induced by Dobutamine was defined as a fall of more than 30 mmHg compared to the arterial pressure before the test or following the preceding level of Dobutamine. Concentric left ventricular hypertrophy (LVH) was defined as a left ventricular mass > 125 g/m2. RESULTS: Among the 89 patients undergoing ESD, 32 (35%) had LVH, 9 of whom (28%) had arterial hypotension, prompting termination of the examination in 4 patients. Among the 57 patients (65%) without LVH, only 2 (3%) had hypotension. All patients with LVH had normal left ventricular function at rest and excellent contractility under stress, with no sign of ischaemia. None of the 31 patients, 5 of whom had LVH, who underwent the test with cycloergometrine had hypotension. CONCLUSION: Hypotension occurring during ESD affects patients more often with LVH (p < 0.001) and excellent systolic function. We postulate that the vigorous contraction of the left ventricle with Dobutamine produces excessive stimulation of the cardiac mechanoreceptors inducing a reflex hypotension. LVH is therefore a marker for patients at risk of hypotension and effort echocardiography is an excellent alternative to this investigation.


Asunto(s)
Agonistas Adrenérgicos beta/efectos adversos , Dobutamina/efectos adversos , Prueba de Esfuerzo/efectos adversos , Hipertrofia Ventricular Izquierda/diagnóstico , Hipotensión/inducido químicamente , Anciano , Presión Sanguínea/efectos de los fármacos , Dobutamina/administración & dosificación , Ecocardiografía/métodos , Prueba de Esfuerzo/métodos , Femenino , Humanos , Hipertensión/epidemiología , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Factores de Riesgo
8.
Europace ; 4(2): 149-53, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12135246

RESUMEN

We report the case of a repetitive and incessant activation of mode switch in a dual chamber pacemaker because of the inappropriate sensing by the atrial lead of far-fields signals from the ventricular evoked response. The incidence, consequences and prevention of the oversensing of far-field QRS complexes are discussed.


Asunto(s)
Sistema de Conducción Cardíaco/fisiopatología , Marcapaso Artificial , Anciano , Electrocardiografía , Falla de Equipo , Humanos , Masculino
9.
J Interv Card Electrophysiol ; 4 Suppl 1: 87-93, 2000 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-10590494

RESUMEN

The artificial activation of the heart modifies the mechanics of contraction and relaxation. While only little basic research has been addressed to this question, clinical observations showed that for hypertrophic as well as dilated cardiomyopathies appropriate pacing techniques can be useful. Pacing can influence the activation sequence. The spread out from a single site is slow, and so hypercontractility deminshed. With the use of multiple electrodes, two atrial and/or two ventricular, conduction delays in the atria or ventricles can be eliminated. Synchronisation of the cardiac activation has an anti-arrhythmic and positiv inotropic effect. This may lead to new indications for pacemakers or better to be named cardiac synchronisers.


Asunto(s)
Estimulación Cardíaca Artificial/métodos , Cardiomiopatía Dilatada/terapia , Cardiomiopatía Hipertrófica/terapia , Contracción Miocárdica/fisiología , Cardiomiopatía Dilatada/diagnóstico , Cardiomiopatía Hipertrófica/diagnóstico , Ensayos Clínicos como Asunto , Femenino , Humanos , Masculino , Marcapaso Artificial , Sensibilidad y Especificidad
10.
Arch Mal Coeur Vaiss ; 92(11): 1479-84, 1999 Nov.
Artículo en Francés | MEDLINE | ID: mdl-10598227

RESUMEN

Infection of a cardiac pacemaker is a rare but serious complication. Percutaneous ablation of the pacemaker and pacing catheter is the only effective treatment. Techniques of extraction of pacing systems have been evaluated but the long term results require analysis. Eighteen patients with infection of cardiac pacemakers underwent extraction of one or more pacing catheters (14 atrial and 20 ventricular) in one same centre. The indication was infection of the pacemaker unit (12 cases) or septicaemia (6 cases) The causal organism was a staphylococcus (aureus: 7 cases, epidermidis: 10 cases, capitis: 1 case). Three techniques were used: 1) direct external manual traction, 2) internal traction with several devices, 3) endovascular counter-traction (Byrd-Cook system). The time from primary implantation of the pacing catheter to its extraction was 42 months and from last pacemaker manipulation to infection, 23 months. The average duration of the extraction procedure was 120 +/- 45 minutes; that of fluoroscopy was 10 +/- 6 minutes. The first technique was used 12 times, the second 8 times and the third 14 times, with complete extraction of the catheter in 88.2% of cases. The metallic tip of the distal electrode embolised in 2 cases and remained stuck in the right ventricle in 1 case. Only one pacing catheter was abandoned. After an average follow-up of 45 months, none of the patients had recurrent infection or any other complication. The authors conclude that extraction of infected pacing catheters is safe and effective. It is the treatment of choice of this complication.


Asunto(s)
Estimulación Cardíaca Artificial/efectos adversos , Marcapaso Artificial/microbiología , Infecciones Relacionadas con Prótesis/etiología , Infecciones Estafilocócicas/etiología , Anciano , Cateterismo Cardíaco/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Marcapaso Artificial/efectos adversos , Infecciones Relacionadas con Prótesis/terapia , Recurrencia , Sepsis/etiología , Infecciones Estafilocócicas/terapia
12.
Ann Cardiol Angeiol (Paris) ; 47(8): 569-75, 1998 Oct.
Artículo en Francés | MEDLINE | ID: mdl-9809141

RESUMEN

UNLABELLED: The authors analysed the long-term clinical and angiographic follow-up of patients after coronary stenting for the treatment of coronary stenosis of a native artery or vein graft. BACKGROUND: The need for revascularization at 6 months and the restenosis rate were decreased after coronary stenting, compared to the conventional percutaneous angioplasty. This benefit appears to persist in the longer term. METHOD: The incidence of major clinical and angiographic complications was evaluated in 129 patients with a minimum follow-up of 3 years. RESULTS: At 6 months, 20% of patients presented a major clinical complication and restenosis was documented in 20% of cases. In the long-term, a major cardiac event was observed in 49% of cases (death: 16%, infarction: 5%, coronary artery bypass graft: 12% and another angioplasty: 16%). Patients treated by stenting during coronary artery bypass graft had a significantly lower survival (60% versus 88%), and a higher incidence of major clinical complications (55% versus 18%), and a higher stent revascularization rate (41% versus 16%). CONCLUSION: The late stent revascularization rate was low. Overall survival was significantly higher in patients treated for a native vessel than in those treated for a coronary artery bypass graft. The complication rate and stent revascularization rate were also significantly lower.


Asunto(s)
Implantación de Prótesis Vascular , Enfermedades Cardiovasculares/cirugía , Enfermedad Coronaria/cirugía , Anciano , Angiopatías Diabéticas , Femenino , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Fumar , Stents
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA